Jumpstart Foundry is now accepting Q2 2024 Applications as they transition into quarterly investments.
NASHVILLE, TENNESSEE, UNITED STATES, February 5, 2024 /EINPresswire.com/ — The Nashville-based healthcare innovation fund is now accepting applications for its Q2 2024 Cohort, with a heightened investment frequency of quarterly funding commencing this year!
Entrepreneurs in the healthcare sector nationwide are invited to submit their applications online for consideration by Jumpstart Foundry. Those selected to join the next cohort will receive a $150K investment and gain access to Jumpstart’s one-of-a-kind program for healthcare founders, known as Jumpstart Insight. This program provides invaluable support in developing the leadership and business management skills necessary to secure funding, build, and effectively manage high-growth healthcare companies.
“Jumpstart Foundry, now raising Fund X, is excited to begin responding more quickly to incredible founders and innovations in healthcare by making quarterly investments,” stated Doug Edwards, CEO of JSF’s parent company, Jumpstart Health Investors. “For nearly a decade Jumpstart Foundry has made investments twice per year. The speed of early-stage healthcare innovation is moving faster than ever, and the need for change in healthcare has never been greater, and we want to respond to that by seeking, reviewing, and investing in the best pre-seed stage innovations in the US faster.”
The application deadline for the next round of funding from JSF is April 5th at 11:59pm CT. To apply for funding, please visit our application page.
Please direct any questions regarding applications to [email protected].
About Jumpstart Foundry:
Jumpstart Foundry is a pre-seed healthcare innovation fund based in Nashville, TN. Previously named one of the most active funds of its kind in the nation, Jumpstart Foundry makes 30-40 investments in early-stage, US-based healthcare startups each year.
Kaylyn Viertel, Marketing Director
Jumpstart Health Investors
email us here
Visit us on social media: